Related Experiment Video

Updated: Jan 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.4K

Impact of Changing Treatment Strategies on Outcomes in Pediatric Ulcerative Colitis

Rishi Bolia1, Jeremy Rajanayagam1, Winita Hardikar1

  • 1Department of Gastroenterology & Clinical Nutrition, The Royal Children's Hospital Melbourne, Australia.

Inflammatory Bowel Diseases
|April 20, 2019
PubMed

Insights

Treatment advances for ulcerative colitis, including biologics, have significantly reduced colectomy rates in children. However, disease flares and hospital admissions remain unchanged, indicating a need for further therapeutic innovation.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Outcomes Analysis

Background:

  • Ulcerative colitis (UC) treatment has evolved with early intervention, biologics, and therapeutic drug monitoring.
  • These advancements aim to improve disease management and patient outcomes in pediatric UC.

Purpose of the Study:

  • To evaluate the impact of modern treatment strategies on disease outcomes in pediatric ulcerative colitis.
  • To assess changes in colectomy rates, disease flares, and hospital admissions over time.

Main Methods:

  • Retrospective review comparing two pediatric UC patient cohorts (2005-2010 vs. 2011-2016).
  • Analysis of demographic data, endoscopic findings, medication use, colectomy rates, disease flares, and hospital admissions.
  • Statistical comparison of outcomes between the two defined time periods.

Main Results:

  • The 2-year cumulative colectomy probability decreased significantly from 14% to 3% (P=0.02) between the two periods.
  • Use of 5-aminosalicylic acid (5-ASA) increased, and biologics like infliximab were introduced earlier.
  • No significant changes were observed in the median number of disease flares or hospital admissions per year.

Conclusions:

  • The introduction of biologics has led to a significant reduction in colectomy rates for pediatric ulcerative colitis.
  • While colectomy rates have improved, disease flare and hospitalization rates remain consistent, highlighting areas for future research.
Abstract

Keywords:
colectomyinfliximabpediatric ulcerative colitis

More Related Videos

Predictive Measurement for Windlass Change in Length and Selected Treatment Outcomes in Chronic Plantar Fasciitis02:15

Predictive Measurement for Windlass Change in Length and Selected Treatment Outcomes in Chronic Plantar Fasciitis

Published on: March 1, 2024

864
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

10.5K

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
482
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
943
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
756
Global Climate Change01:50

Global Climate Change

Throughout its ~4.5 billion year history, the Earth has experienced periods of warming and cooling. However, the current drastic increase in global temperatures is well outside of the Earth’s cyclic norms, and evidence for human-caused global climate change is compelling. Paleoclimatology, the study of ancient climate conditions, provides ample evidence for human-caused global climate change by comparing recent conditions with those in the past.
28.8K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.4K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K